FOR RESEARCH USE ONLY
Early human researchLongevity research

Epitalon

Synthetic pineal tetrapeptide researched for telomerase activation, circadian regulation and longevity biomarkers.

01Telomerase biology02Pineal signalling03Circadian research
Molecular signature / epitalon
Structural identity

Synthetic tetrapeptide derived from pineal-gland research

Also known as

Epithalon · Ala-Glu-Asp-Gly · AEDG tetrapeptide

Research-use context

In-vitro and laboratory information only. No human-use recommendation.

Guide contentsOpen in calculator
Section 01

Compound briefing

Epitalon (Ala-Glu-Asp-Gly) is a synthetic tetrapeptide developed from epithalamin, a peptide isolated from the bovine pineal gland. It has been studied for telomerase activation, telomere elongation, melatonin-axis normalisation and broader geroprotective effects in animal and early human research.

The research question

Epitalon is studied at the intersection of pineal signalling, circadian regulation and cellular ageing. Telomere-related measurements, melatonin rhythms and lifespan claims describe very different levels of evidence and should not be conflated.

Section 02

Mechanism & research themes

Activates telomerase in somatic cells via regulation of the hTERT gene, potentially elongating telomeres and extending cellular replicative lifespan. Also normalises pineal melatonin secretion and modulates gene expression patterns associated with ageing.

01

Telomerase activation and telomere lengthening in cell and animal models

02

Normalisation of pineal melatonin secretion and circadian rhythms

03

Improved antioxidant enzyme status in ageing research

04

Potential extension of healthy lifespan markers in animal studies

05

Support for immune and neuroendocrine function in older subjects

06

Favourable tolerability profile across reported research

These are research themes reported across the literature, not established benefits or indications.

Section 03

Evidence assessment

Early human research

Small human reports and animal studies sit alongside cell findings, with limited independent replication. Telomerase activation is a mechanistic observation, not evidence of extended human lifespan.

What to look for

Controlled design, a defined preparation, clinically relevant endpoints and independent replication carry more weight than a single mechanism study.

What not to assume

A plausible pathway does not establish efficacy. Results across different routes, formulations and populations are not automatically interchangeable.

Section 04

Protocol literature

Commonly referenced research protocols use 5–10mg subcutaneously once daily, typically for 10–20 consecutive days, followed by a 4–6 month break before repeating. Some longevity protocols use 2–3 short courses per year.

Reported persistence

Plasma half-life is short (minutes); functional effects are believed to persist through gene-expression and telomerase changes rather than direct receptor occupancy.

Calculator starting point

10 mg per reference dose

7 doses per week · 2-week cycle

1 mL default reconstitution volume

10 mg/day SC for 10–20 days; repeat course every 4–6 months.

Calculator defaults are editable mathematical reference values, not dosing advice. Verify all calculations independently.

Calculate Epitalon
Section 05

Laboratory handling

Reconstitution reference

Reconstitute a 10mg vial with 1–2mL bacteriostatic water for a 5–10mg/mL working concentration. Swirl gently.

Storage reference

Lyophilised: 2–8°C, stable 18–24 months. Reconstituted: 2–8°C, protect from light, use within 30 days.

Minimum documentation standard

  • Record the lot identifier and review its matching analytical documentation.
  • Use aseptic technique and record diluent, final volume and calculated concentration.
  • Label preparation date, storage conditions and any light or freeze–thaw restrictions.
  • Inspect before each use and investigate unexpected colour, clarity or particulate changes.
Section 06

Limitations & safety

L1

Human RCT data is limited and primarily from Russian-language literature.

L2

Effects require repeated short courses rather than continuous daily use.

L3

Long-term safety and optimal dosing intervals are not well established.

Research use only

This field note is an educational literature summary, not medical advice or a recommendation for human use. Safety statements are limited by the quality and duration of the available evidence.

Continue reading

Related field notes

Back to all field notes

Welcome to HV Labs

Please confirm your age to continue.

For research use only